Clinical Trials Logo

Concussions clinical trials

View clinical trials related to Concussions.

Filter by:
  • None
  • Page 1

NCT ID: NCT03415048 Recruiting - Concussions Clinical Trials

Longitudinal Study of Children With Concussions

Start date: September 2014
Phase: N/A
Study type: Observational [Patient Registry]

For children and adolescents who have had a concussion resulting in prolonged symptoms (>3 months), the investigators will: 1. Measure post-concussion symptoms, cognitive and emotional function during the 3 years post-injury. 2. Determine length of recovery and frequency of return to prior level of sports participation. 3. Determine the incidence of and risk factors for subsequent concussion during the 3 years post-injury.

NCT ID: NCT02893969 Completed - Clinical trials for Post-Concussive Symptoms

Pediatric Concussion Assessment of Rest and Exertion

PedCARE
Start date: March 6, 2017
Phase: N/A
Study type: Interventional

The goal of this study is to investigate when is the best time to resume physical activity following a head injury. Two treatment plans will be studied; the first treatment plan consists of gradually reintroducing physical activity in the child's routine, starting 72 hours following the head injury. The second treatment plan involves physical and mental rest until the child as no more symptoms. Once symptom free, physical activity is gradually reintroduced in the child's routine.

NCT ID: NCT01873287 Completed - Concussions Clinical Trials

Predicting Persistent Postconcussive Problems in Pediatrics (5P)

5P
Start date: August 2013
Phase:
Study type: Observational

Concussion, a mild traumatic injury common in children and adolescents, is a complex pathophysiological process affecting the brain. The lay press is inundated with reports of tragic consequences of concussion, and children are not immune. Persistent postconcussive symptoms (PCS) is defined as the persistence of somatic, cognitive, physical, psychological or behavioural changes lasting more than one month following injury. PCS significantly impacts children and their family's quality of life through school absenteeism, depressed mood and loss of activities. Validated, easy-to-use prognosticators do not exist for clinicians to identify children at highest risk for PCS. As a result,physicians cannot accurately inform children and parents whether they should expect longer symptoms, nor initiate pharmacotherapy or other management to reduce the occurrence or severity of PCS. The investigators objective is to derive and validate a clinical prediction rule for the development of PCS in children and adolescents presenting to the emergency department (ED) following acute head injury. The investigators have three aims: (1) determine PCS incidence at one-month follow-up in children aged 5-17 who sustain a concussion; (2) derive a rule to predict PCS from variables present in the history and physical examination; and, (3) assess the accuracy, reliability and acceptability of the prediction rule in a subsequent cohort. Using a prospective, multicentre study at nine large Canadian pediatric EDs, the investigators will recruit the largest prospective epidemiological cohort of children with concussions in the literature. This work will provide rigorous evidence to determine PCS incidence in children and its impact on quality of life. The results will enable clinicians to identify children at highest risk for PCS, optimize treatment and provide families with realistic anticipatory guidance. This study will also establish a strong and vital evidence base to advance concussion research.